Bridging communication gaps between hearing and hearing-impaired individuals is an important challenge in assistive ...

Industrial production in Europe’s largest economy continued to accelerate in October, with the sector showing further signs of stabilization as it awaits large-scale government investment. Output ...

Police use of live facial recognition (LFR) technology reconfigures suspicion in subtle yet important ways, undermining so-called human-in-the-loop safeguards. Despite the long-standing controversies ...

New facial-recognition tools being tested at Orlando International Airport could soon be keeping track of travelers at departure gates across the country. By Christine Chung Reporting from Orlando, ...

The distinction for the Lumbee Tribe in North Carolina, signed into law on Thursday, opens access to federal support and defies challenges from other tribes over their legitimacy. By Rick Rojas ...

It’s time to uncork the prosecco and maybe order a plate of tagliatelle al ragù for the table. Italy has a very tasty reason to celebrate: Its national cuisine has become the first entire gastronomic ...

At long last, Brandi Glanville is receiving answers to her years-long health struggle. Glanville, 53, told TMZ in an interview published on Friday, December 5, that she received an official diagnosis ...

Several government employees in China are under investigation after being caught using face masks printed with their coworkers’ faces to bypass facial recognition attendance systems. According to ...

Save $50 on the Contour Face with our exclusive code during Omnilux's sale through tonight. After eight months of extensive testing nine popular LED face masks, our beauty editors say that the the ...

The study evaluated the efficacy and safety of the investigational immunotherapy combination of TECVAYLI ® plus DARZALEX FASPRO ® versus DARZALEX FASPRO ® and dexamethasone with either pomalidomide or ...

ORLANDO, Fla., Dec. 9, 2025 /PRNewswire/ -- Johnson & Johnson (NYSE:JNJ), the worldwide leader in multiple myeloma, today announced new data from the investigational Phase 3 MajesTEC-3 study that ...